Clinical Trials List
2023-03-11 - 2027-03-01
Phase III
Not yet recruiting1
Recruiting7
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
Trial Applicant
TAIWAN PSI HEALTH DEVELOPMENT COMPANY LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Shen Liang Shih Division of General Surgery
- Fang-Ming Chen Division of General Surgery
- 甘蓉瑜 Division of General Surgery
- 高捷妮 Division of General Surgery
- Junping Shiau Shiau Division of General Surgery
- Chung-Liang Li Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
- 巫承哲 Division of General Surgery
- 高理鈞 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jui-Hung Tsai
- 黃怡菁 Division of General Surgery
- Wei-Pang Chung Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- 楊舜如 Division of Hematology & Oncology
- Shang-Hung Chen
- Zhu-Jun Loh
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李佳真 Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- 羅喬 Division of General Surgery
- 林季宏 Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 楊明翰 Division of Hematology & Oncology
- MING-YANG WANG Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- 黃柏翔 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HUI-WEN LIU Division of Hematology & Oncology
- 蘇智銘 Division of General Surgery
- Wei-Hong Cheng Division of Hematology & Oncology
- 廖立民 Division of General Surgery
- KA-WAI TAM Division of General Surgery
- 莊博雅 Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
- 蔡承志 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 邱仁輝 Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- 賴亦貞 Division of Radiology
- 陳彥蓁 Division of General Surgery
- Ta-Chung Chao Division of General Surgery
- Jiun-I Lai Division of Hematology & Oncology
- 林燕淑 Division of General Surgery
- 馮晉榮 Division of General Surgery
- Yi-Fang Tsai Division of General Surgery
- 陳柏方 Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
- 鄭涵方 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HWEI-CHUNG WANG Division of General Surgery
- 黃至豪 Division of General Surgery
- Chen-Teng Wu Division of General Surgery
- Chih-Jung Chen Division of General Surgery
- Yao-Chung Wu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
34 participants
-
Global
701 participants
